ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.6 Million USD | -40.96% |
| 2022 | 2.71 Million USD | -15.14% |
| 2021 | 3.19 Million USD | 2179.45% |
| 2020 | 140.16 Thousand USD | 71.09% |
| 2019 | 81.92 Thousand USD | 107.95% |
| 2018 | 39.39 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.56 Million USD | 0.01% |
| 2024 Q2 | 1.53 Million USD | -1.27% |
| 2023 Q3 | 4.57 Million USD | 21.92% |
| 2023 FY | 1.6 Million USD | -40.96% |
| 2023 Q4 | 1.6 Million USD | -65.0% |
| 2023 Q2 | 3.75 Million USD | 18.61% |
| 2023 Q1 | 3.16 Million USD | 16.66% |
| 2022 Q3 | 4.77 Million USD | -15.5% |
| 2022 Q1 | 3.86 Million CAD | 20.83% |
| 2022 Q4 | 2.71 Million USD | -43.23% |
| 2022 FY | 2.71 Million USD | -15.14% |
| 2022 Q2 | 5.65 Million CAD | 46.35% |
| 2021 Q2 | 1.61 Million CAD | -11.92% |
| 2021 Q1 | 1.83 Million CAD | 926.75% |
| 2021 Q4 | 3.19 Million USD | -6.91% |
| 2021 FY | 3.19 Million USD | 2179.45% |
| 2021 Q3 | 3.43 Million CAD | 112.58% |
| 2020 Q3 | 144.23 Thousand CAD | 9.07% |
| 2020 Q2 | 132.23 Thousand CAD | 9.98% |
| 2020 Q1 | 120.23 Thousand CAD | 13.18% |
| 2020 FY | 140.16 Thousand USD | 71.09% |
| 2020 Q4 | 178.57 Thousand CAD | 23.8% |
| 2019 Q4 | 106.23 Thousand CAD | 0.0% |
| 2019 FY | 81.92 Thousand USD | 107.95% |
| 2018 FY | 39.39 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | 55.638% |
| Arrayit Corporation | 7.49 Million USD | 78.649% |
| Atlantic International Corp. | 3.82 Million USD | 58.194% |
| Biocept, Inc. | 22.01 Million USD | 92.729% |
| Bioqual, Inc. | 18.93 Million USD | 91.548% |
| CardioGenics Holdings Inc | 1.79 Million USD | 10.827% |
| DermTech, Inc. | 64.75 Million USD | 97.528% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 99.782% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 87.077% |
| iMD Companies, Inc. | 1.67 Million USD | 4.398% |
| IDenta Corp. | 1.01 Million USD | -57.98% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 94.315% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -437.205% |
| InVitro International | 78.99 Thousand USD | -1926.316% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 91.887% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -1137.915% |
| Medical Imaging Corp. | 9.51 Million USD | 83.182% |
| NovelStem International Corp. | 4.2 Million USD | 61.946% |
| Optigenex Inc. | 9.57 Million USD | 83.276% |
| PharmChem, Inc. | 558.64 Thousand USD | -186.511% |
| Proteome Sciences plc | 18.48 Million USD | 91.343% |
| Response Genetics, Inc | 15.86 Million USD | 89.912% |
| Rennova Health, Inc. | 49.66 Million USD | 96.777% |
| RushNet, Inc. | 6.23 Million USD | 74.345% |
| Stella Diagnostics Inc. | 18 Million USD | 91.111% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 80.49% |
| Todos Medical Ltd. | 50.15 Million USD | 96.809% |